Compounds > 5-hydroxy-7,8-dimethoxyflavone
Page last updated: 2024-09-05

5-hydroxy-7,8-dimethoxyflavone and bi 2536

5-hydroxy-7,8-dimethoxyflavone has been researched along with bi 2536 in 1 studies

Compound Research Comparison

Studies
(5-hydroxy-7,8-dimethoxyflavone)		Trials
(5-hydroxy-7,8-dimethoxyflavone)		Recent Studies (post-2010)
(5-hydroxy-7,8-dimethoxyflavone)		Studies
(bi 2536)		Trials
(bi 2536)		Recent Studies (post-2010) (bi 2536)
110619313169

Protein Interaction Comparison

ProteinTaxonomy5-hydroxy-7,8-dimethoxyflavone (IC50)bi 2536 (IC50)
Bromodomain-containing protein 4Homo sapiens (human)0.1211
Cytochrome P450 3A4Homo sapiens (human)0.0593
Transcription initiation factor TFIID subunit 1Homo sapiens (human)0.16
Serine/threonine-protein kinase PLK1Homo sapiens (human)0.0549
Bromodomain testis-specific proteinHomo sapiens (human)0.83
Serine/threonine-protein kinase PLK3Homo sapiens (human)0.0148
Serine/threonine-protein kinase PLK2Homo sapiens (human)0.0123
ALK tyrosine kinase receptorHomo sapiens (human)0.408

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ouyang, L; Wang, J; Wang, Y; Zhang, J; Zhang, L1

Reviews

1 review(s) available for 5-hydroxy-7,8-dimethoxyflavone and bi 2536

ArticleYear
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential.
    Journal of medicinal chemistry, 2022, 08-11, Volume: 65, Issue:15

    Topics: Antineoplastic Agents; Cell Cycle Proteins; Humans; Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins

2022